Microbes with higher metabolic independence are enriched in human gut microbiomes under stress

Curation statements for this article:
  • Curated by eLife

    eLife logo

    eLife assessment

    This study describes an important bioinformatics tool for normalizing gene copy number from metagenomic assemblies. The tool is used in a meta-analysis of data from inflammatory bowel disease (IBD) patients and healthy controls. While some of the evidence for the power of the method is compelling, other evidence seems incomplete. The inclusion of additional computational and/or experimental validation would markedly strengthen the study. This paper will likely be of broad interest to researchers studying the role of complex microbial communities in host health and disease.

This article has been Reviewed by the following groups

Read the full article See related articles

Abstract

A wide variety of human diseases are associated with loss of microbial diversity in the human gut, inspiring a great interest in the diagnostic or therapeutic potential of the microbiota. However, the ecological forces that drive diversity reduction in disease states remain unclear, rendering it difficult to ascertain the role of the microbiota in disease emergence or severity. One hypothesis to explain this phenomenon is that microbial diversity is diminished as disease states select for microbial populations that are more fit to survive environmental stress caused by inflammation or other host factors. Here, we tested this hypothesis on a large scale, by developing a software framework to quantify the enrichment of microbial metabolisms in complex metagenomes as a function of microbial diversity. We applied this framework to over 400 gut metagenomes from individuals who are healthy or diagnosed with inflammatory bowel disease (IBD). We found that high metabolic independence (HMI) is a distinguishing characteristic of microbial communities associated with individuals diagnosed with IBD. A classifier we trained using the normalized copy numbers of 33 HMI-associated metabolic modules not only distinguished states of health versus IBD, but also tracked the recovery of the gut microbiome following antibiotic treatment, suggesting that HMI is a hallmark of microbial communities in stressed gut environments.

Article activity feed

  1. eLife assessment

    This study describes an important bioinformatics tool for normalizing gene copy number from metagenomic assemblies. The tool is used in a meta-analysis of data from inflammatory bowel disease (IBD) patients and healthy controls. While some of the evidence for the power of the method is compelling, other evidence seems incomplete. The inclusion of additional computational and/or experimental validation would markedly strengthen the study. This paper will likely be of broad interest to researchers studying the role of complex microbial communities in host health and disease.

  2. Reviewer #1 (Public Review):

    In this work, Veseli et al. present a computational framework to infer the functional diversity of microbiomes in relation to microbial diversity directly from metagenomic data. The framework reconstructs metabolic modules from metagenomes and calculates the per-population copy number of each module, resulting in the proportion of microbes in the sample carrying certain genes. They applied this framework to a dataset of gut microbiomes from 109 inflammatory bowel disease (IBD) patients, 78 patients with other gastrointestinal conditions, and 229 healthy controls. They found that the microbiomes of IBD patients were enriched in a high fraction of metabolic pathways, including biosynthesis pathways such as those for amino acids, vitamins, nucleotides, and lipids. Hence, they had higher metabolic independence compared with healthy controls. To an extent, the authors also found a pathway enrichment suggesting higher metabolic independence in patients with gastrointestinal conditions other than IBD indicating this could be a signal for a general loss in host health. Finally, a machine learning classifier using high metabolic independence in microbiomes could predict IBD with good accuracy. Overall, this is an interesting and well-written article and presents a novel workflow that enables a comprehensive characterization of microbiome cohorts.

  3. Reviewer #2 (Public Review):

    This study builds upon the team's recent discovery that antibiotic treatment and other disturbances favour the persistence of bacteria with genomes that encode complete modules for the synthesis of essential metabolites (Watson et al. 2023). Veseli and collaborators now provide an in-depth analysis of metabolic pathway completeness within microbiomes, finding strong evidence for an enrichment of bacteria with high metabolic independence in the microbiomes associated with IBD and other gastrointestinal disorders. Importantly, this study provides new open-source software to facilitate the reconstruction of metabolic pathways, estimate their completeness and normalize their results according to species diversity. Finally, this study also shows that the metabolic independence of microbial communities can be used as a marker of dysbiosis. The function-based health index proposed here is more robust to individuals' lifestyles and geographic origin than previously proposed methods based on bacterial taxonomy.

    The implications of this study have the potential to spur a paradigm shift in the field. It shows that certain bacterial taxa that have been consistently associated with disease might not be harmful to their host as previously thought. These bacteria seem to be the only species that are able to survive in a stressed gut environment. They might even be important to rebuild a healthy microbiome (although the authors are careful not to make this speculation).

    This paper provides an in-depth discussion of the results, and limitations are clearly addressed throughout the manuscript. Some of the potential limitations relate to the use of large publicly available datasets, where sample processing and the definition of healthy status varies between studies. The authors have recognised these issues and their results were robust to analyses performed on a per-cohort basis. These potential limitations, therefore, are unlikely to have affected the conclusions of this study.

    Overall, this manuscript is a magnificent contribution to the field, likely to inspire many other studies to come.

  4. Reviewer #3 (Public Review):

    The major strength of this manuscript is the "anvi-estimate-metabolism' tool, which is already accessible online, extensively documented, and potentially broadly useful to microbial ecologists. However, the context for this tool and its validation is lacking in the current version of the manuscript. It is unclear whether similar tools exist; if so, it would help to benchmark this new tool against prior methods. Simulated datasets could be used to validate the approach and test its robustness to different levels of bacterial richness, genome sizes, and annotation level.

    The concept of metabolic independence was intriguing, although it also raises some concerns about the overinterpretation of metagenomic data. As mentioned by the authors, IBD is associated with taxonomic shifts that could confound the copy number estimates that are the primary focus of this analysis. It is unclear if the current results can be explained by IBD-associated shifts in taxonomic composition and/or average genome size. The level of prior knowledge varies a lot between taxa; especially for the IBD-associated gamma-Proteobacteria. It can be difficult to distinguish genes for biosynthesis and catabolism just from the KEGG module names and the new normalization tool proposed herein markedly affects the results relative to more traditional analyses. As such, it seems safer to view the current analysis as hypothesis-generating, requiring additional data to assess the degree to which metabolic dependencies are linked to IBD.